P Diot, L Morra and GC Smaldone
Department of Medicine, State University of New York at Stony Brook 11794-8172, USA.

Using an in vitro model, we compared efficiencies of jet nebulizers and metered-dose inhalers (MDI) with actuator devices to deliver albuterol in various conditions of mechanical ventilation. Factors tested included influence of humidification, MDI actuator device (Aerovent spacer or Marquest 172275 MDI adaptor), and synchronization of MDI to the respiratory cycle. With the nebulizer (AeroTech II) filled with 2.5 mg albuterol sulfate in 3 ml water and run until dry, inhaled mass was 42 +/- 2.6% and mass median aerodynamic diameter (MMAD) was 1.3 microns on a nonhumidified circuit. With the MDI+ Aerovent, the inhaled mass percentage per 90 microgm puff was 15.4 +/- 0.2% with humidification and 25.1 +/- 3.7% without humidification, actuations being synchronized with the beginning of inspiration and separated by a 1-min pause. Failure to synchronize actuations with inspiration or to pause 1 min resulted in significant reductions in inhaled mass (by 35 and 72%, respectively). The Marquest adaptor was less efficient, with an inhaled mass of 7.2 +/- 0.7% under optimal conditions. Metered-dose inhaler actuation during expiration resulted in relatively large particles (MMAD = 2.0 microns). All other MDI actuations led to essentially biphasic distributions, with particles greater than 1 micron following a distribution similar to the nebulizer and the overall MMAD estimated to be 0.22 microns. The AeroTech II delivered a cumulative 1,000 micrograms of drug (2,500 x 0.40) over 40 min. To achieve that amount, the MDI connected to the Aerovent and used in its most efficient sequence would require 45 timed puffs (90 micrograms per puff, 25.1% mean inhaled mass) and take 45 min of an experienced therapist's time.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				T. G. O'Riordan, W. Mao, L. B. Palmer, and J. J. Chen Assessing the Effects of Racemic and Single-Enantiomer Albuterol on Airway Secretions in Long-term Intubated Patients Chest, January 1, 2006; 129(1): 124 - 132. [Abstract] [Full Text] [PDF]

				M. Tzoufi, S. D. Mentzelopoulos, C. Roussos, and A. Armaganidis The Effects of Nebulized Salbutamol, External Positive End-Expiratory Pressure, and Their Combination on Respiratory Mechanics, Hemodynamics, and Gas Exchange in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients Anesth. Analg., September 1, 2005; 101(3): 843 - 850. [Abstract] [Full Text] [PDF]

				M. B. Dolovich, R. C. Ahrens, D. R. Hess, P. Anderson, R. Dhand, J. L. Rau, G. C. Smaldone, and G. Guyatt Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology Chest, January 1, 2005; 127(1): 335 - 371. [Abstract] [Full Text] [PDF]

				R. Dhand Aerosol Therapy during Mechanical Ventilation: Getting Ready for Prime Time Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1148 - 1149. [Full Text] [PDF]

				D. D. Miller, M. M. Amin, L. B. Palmer, A. R. Shah, and G. C. Smaldone Aerosol Delivery and Modern Mechanical Ventilation: In Vitro/In Vivo Evaluation Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1205 - 1209. [Abstract] [Full Text] [PDF]

				S S Garner, D B Wiest, J W Bradley, and D M Habib Two administration methods for inhaled salbutamol in intubated patients Arch. Dis. Child., July 1, 2002; 87(1): 49 - 53. [Abstract] [Full Text] [PDF]

				M. L. GOODE, J. B. FINK, R. DHAND, and M. J. TOBIN Improvement in Aerosol Delivery with Helium-Oxygen Mixtures during Mechanical Ventilation Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 109 - 114. [Abstract] [Full Text]

				C. F. LANGE and W. H. FINLAY Overcoming the Adverse Effect of Humidity in Aerosol Delivery via Pressurized Metered-Dose Inhalers during Mechanical Ventilation Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1614 - 1618. [Abstract] [Full Text]

				M. A. Jantz and N. A. Collop Bronchodilator Aerosol Delivery in Mechanical Ventilation: Jantz MA, Collop NA Bronchodilator Aerosol Delivery in Mechanical Ventilation Intensive Care Med 1999,14 166-183 J Intensive Care Med, July 1, 1999; 14(4): 166 - 183. [PDF]

				P. Marik, J. Hogan, and J. Krikorian A Comparison of Bronchodilator Therapy Delivered by Nebulization and Metered-Dose Inhaler in Mechanically Ventilated Patients Chest, June 1, 1999; 115(6): 1653 - 1657. [Abstract] [Full Text] [PDF]

				G. C. Smaldone Aerosolized Bronchodilators in the Intensive Care Unit . Much Ado about Nothing? Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1029 - 1030. [Full Text] [PDF]

				C. GUERIN, A. CHEVRE, P. DESSIRIER, T. PONCET, M.-H. BECQUEMIN, P. F. DEQUIN, C. LE GUELLEC, D. JACQUES, and G. FOURNIER Inhaled Fenoterol-Ipratropium Bromide in Mechanically Ventilated Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1036 - 1042. [Abstract] [Full Text] [PDF]

				J. B. FINK, R. DHAND, J. GRYCHOWSKI, P. J. FAHEY, and M. J. TOBIN Reconciling In Vitro and In Vivo Measurements of Aerosol Delivery from a Metered-Dose Inhaler during Mechanical Ventilation and Defining Efficiency-enhancing Factors Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 63 - 68. [Abstract] [Full Text]

				R. DHAND and M. J. TOBIN Inhaled Bronchodilator Therapy in Mechanically Ventilated Patients Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 3 - 10. [Full Text]